These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16246083)

  • 21. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility.
    Arendrup MC; Fuursted K; Gahrn-Hansen B; Schønheyder HC; Knudsen JD; Jensen IM; Bruun B; Christensen JJ; Johansen HK
    Clin Microbiol Infect; 2008 May; 14(5):487-94. PubMed ID: 18294241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug resistance in yeast Candida.
    Prasad R; Kapoor K
    Int Rev Cytol; 2005; 242():215-48. PubMed ID: 15598470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced susceptibility of Candida albicans clinical isolates to azoles and detection of mutations in the ERG11 gene.
    Zhang L; Yang HF; Liu YY; Xu XH; Ye Y; Li JB
    Diagn Microbiol Infect Dis; 2013 Dec; 77(4):327-9. PubMed ID: 24070847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prevalence of vaginal candidiasis in pregnant women. Identification of yeasts and susceptibility to antifungal agents].
    García Heredia M; García SD; Copolillo EF; Cora Eliseth M; Barata AD; Vay CA; de Torres RA; Tiraboschi N; Famiglietti AM
    Rev Argent Microbiol; 2006; 38(1):9-12. PubMed ID: 16784126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum or bile affects the in vitro azole susceptibilities of Candida spp.
    Nagi M; Tanabe K; Takano Y; Kikuchi K; Miyazaki Y; Niimi M
    Jpn J Infect Dis; 2009 Jul; 62(4):306-8. PubMed ID: 19628912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between enzyme production, germ tube formation and susceptibility to fluconazole in Candida species isolated from patients with denture-related stomatitis and control individuals.
    Pinto E; Ribeiro IC; Ferreira NJ; Fortes CE; Fonseca PA; Figueiral MH
    J Oral Pathol Med; 2008 Nov; 37(10):587-92. PubMed ID: 18764856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
    Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
    Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults.
    Gualco L; Debbia EA; Bandettini R; Pescetto L; Cavallero A; Ossi MC; Schito AM; Marchese A
    Int J Antimicrob Agents; 2007 Feb; 29(2):179-84. PubMed ID: 17175140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of essential oils extracted from plants used as spices against fluconazole-resistant and fluconazole-susceptible Candida spp.
    Pozzatti P; Scheid LA; Spader TB; Atayde ML; Santurio JM; Alves SH
    Can J Microbiol; 2008 Nov; 54(11):950-6. PubMed ID: 18997851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro antifungal susceptibility of clinical isolates of Candida spp. obtained from patients with different predisposing factors to candidosis.
    Pinto PM; Weikert-Oliveira Rde C; Lyon JP; Cury VF; Arantes RR; Koga-Ito CY; Resende MA
    Microbiol Res; 2008; 163(5):579-85. PubMed ID: 16962755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.
    Mokaddas E; Khan ZU; Ahmad S
    Mycoses; 2011 Jul; 54(4):e29-34. PubMed ID: 20002881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.
    Pfaller MA; Diekema DJ; Colombo AL; Kibbler C; Ng KP; Gibbs DL; Newell VA
    J Clin Microbiol; 2006 Oct; 44(10):3578-82. PubMed ID: 17021085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of resistance to azole antifungals.
    Marichal P; Vanden Bossche H
    Acta Biochim Pol; 1995; 42(4):509-16. PubMed ID: 8852341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis and Candida kefyr.
    Gil-Lamaignere C; Müller FM
    Int J Antimicrob Agents; 2004 May; 23(5):520-3. PubMed ID: 15120736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.
    Xu Y; Chen L; Li C
    J Antimicrob Chemother; 2008 Apr; 61(4):798-804. PubMed ID: 18218640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana.
    Adjapong G; Hale M; Garrill A
    Med Mycol; 2017 Aug; 55(6):686-689. PubMed ID: 27838642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance.
    Jabra-Rizk MA; Shirtliff M; James C; Meiller T
    FEMS Yeast Res; 2006 Nov; 6(7):1063-73. PubMed ID: 17042756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Jewtuchowicz VM; Mujica MT; Brusca MI; Sordelli N; Malzone MC; Pola SJ; Iovannitti CA; Rosa AC
    Oral Microbiol Immunol; 2008 Dec; 23(6):505-9. PubMed ID: 18954358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management.
    Chen SC; Marriott D; Playford EG; Nguyen Q; Ellis D; Meyer W; Sorrell TC; Slavin M;
    Clin Microbiol Infect; 2009 Jul; 15(7):662-9. PubMed ID: 19614718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.